Literature DB >> 26461902

Oseltamivir for influenza - Authors' reply.

Arnold S Monto1, Joanna Dobson2, Stuart Pocock2, Richard J Whitley3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26461902     DOI： 10.1016/S0140-6736(15)00204-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews.

Authors:  Shai Mulinari; Courtney Davis
Journal:  Health Res Policy Syst       Date:  2017-11-09

2.  Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: a randomized controlled trial.

Authors:  Min Li; Guang-Chao Han; Yang Chen; Wen-Xiu Du; Fang Liu; Yu-Min Chi; Jun-Feng Du
Journal:  Braz J Med Biol Res       Date:  2020-11-27       Impact factor: 2.590
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.